Dual-parameter immunoflow cytometry in diagnosis and follow-up of patients with bladder cancer.
- 1 January 1998
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 34 (6) , 492-499
- https://doi.org/10.1159/000019789
Abstract
The aim of this study was to evaluate the clinical significance of a dual-parameter immunoflow cytometry (DPI-FCM) assay in the detection of tumor cells in barbotage specimens of bladder cancer patients.Keywords
This publication has 0 references indexed in Scilit: